The document summarizes an open innovation challenge hosted by MedImmune Biologics, a unit of AstraZeneca, to generate ideas for real business challenges. Eight challenges were presented to multi-disciplinary university student teams, who received background information and worked with a MedImmune mentor to develop novel and feasible ideas over one week. The ideas were then presented and assessed, with over ten found to be worth further developing. The event was deemed a success by MedImmune and participants, addressing real challenges, improving MedImmune's profile, and generating new ideas. MedImmune aims to expand this open innovation approach internally and externally going forward.